The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer
Authors
Keywords
CA72-4, Gastric cancer, Biomarker, Predictor, Targeted therapy
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1876, Issue 2, Pages 188634
Publisher
Elsevier BV
Online
2021-10-16
DOI
10.1016/j.bbcan.2021.188634
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
- (2021) Yilin Tong et al. BMC CANCER
- Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
- (2021) Runzhe Shu et al. Molecular Therapy-Oncolytics
- Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer
- (2021) Liang Guo et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Association of preoperative and postoperative CA72‐4 with gastric cancer outcome
- (2021) Ting Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
- (2021) Yunjin Yao et al. Frontiers in Genetics
- Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies
- (2021) Lornella Seeneevassen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Highly Sensitive and Cost-Effective Portable Sensor for Early Gastric Carcinoma Diagnosis
- (2021) Saw-Lin Oo et al. SENSORS
- Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
- (2021) Wei Xu et al. Frontiers in Oncology
- Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
- (2021) Zining Liu et al. BMC GASTROENTEROLOGY
- Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer
- (2021) Zengbao Lin et al. Journal of Gastrointestinal Oncology
- Current immunoassay methods and their applications to clinically used biomarkers of breast cancer
- (2020) Seri Jeong et al. CLINICAL BIOCHEMISTRY
- Precision Medicine Approaches to Prevent Gastric Cancer
- (2020) Juntaro Matsuzaki et al. Gut and Liver
- Diagnostic and prognostic values of anti‐helicobacter pylori antibody combined with serum CA724, CA19‐9, and CEA for young patients with early gastric cancer
- (2020) Xuyang Gong et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis
- (2020) Alexander Charles Ford et al. GUT
- Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination
- (2020) Jessica S. Bolton et al. MALARIA JOURNAL
- Evaluation of the value of multiparameter combined analysis of serum markers in the early diagnosis of gastric cancer
- (2020) Zhi-Guo Zhang et al. World Journal of Gastrointestinal Oncology
- A radiomics-based model for prediction of lymph node metastasis in gastric cancer
- (2020) Xujie Gao et al. EUROPEAN JOURNAL OF RADIOLOGY
- TAG-72 targeted α-radionuclide therapy of ovarian cancer using actinium-225 labeled DOTAylated-huCC49 antibody
- (2020) Megan Minnix et al. JOURNAL OF NUCLEAR MEDICINE
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Electrochemical immunosensor based on binary nanoparticles decorated rGO-TEPA as magnetic capture and Au@PtNPs as probe for CEA detection
- (2020) Liangli Cao et al. Microchimica Acta
- Artificial intelligence in gastric cancer: Application and future perspectives
- (2020) Peng-Hui Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Non-Invasive Early Molecular Detection of Gastric Cancers
- (2020) Hiroyuki Yamamoto et al. Cancers
- Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
- (2020) William M. Grady et al. GASTROENTEROLOGY
- Correlation between tumor marker CA72-4 and prognosis of patients with gastric cancer
- (2020) Minxia Li et al. MEDICINE
- Evaluation of an Element-Tagged Duplex Immunoassay Coupled with Inductively Coupled Plasma Mass Spectrometry Detection: A Further Study for the Application of the New Assay in Clinical Laboratory
- (2020) Wencan Jiang et al. MOLECULES
- The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1
- (2019) Jingjing Yang et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer
- (2019) Jiejie Qin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
- (2019) Giovanna Rossi et al. CANCER RESEARCH
- Recent advances in gastric cancer early diagnosis
- (2019) Laura Necula et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis
- (2019) Hong Jiang et al. PATHOLOGY RESEARCH AND PRACTICE
- Spatial distribution characteristics of tumor marker CA724 reference values in China
- (2019) Jing Jing et al. Cancer Medicine
- Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer
- (2019) Jun Lu et al. DISEASE MARKERS
- Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
- (2019) Chao Huang et al. Frontiers in Oncology
- Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
- (2019) Wei Peng et al. Scientific Reports
- The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
- (2018) Oliver A. Zill et al. CLINICAL CANCER RESEARCH
- Prevalence and causes of abnormal PSA recovery
- (2018) Noémie Lautenbach et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer
- (2018) Rui Zhao et al. Molecular Cancer
- Biomarkers of gastric cancer: Current topics and future perspective
- (2018) Tasuku Matsuoka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Multiple cytokine profiling in serum for early detection of gastric cancer
- (2018) Jian Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells
- (2018) Ting-Ting Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV
- (2018) Wei Ge et al. Gastroenterology Research and Practice
- Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
- (2018) Raffaella Rossin et al. Nature Communications
- Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
- (2018) Magdalena Cisło et al. Oncotarget
- Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
- (2018) Shufang Ning et al. Journal of Cancer
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer
- (2018) Muhammad Abbas et al. CURRENT PROBLEMS IN CANCER
- Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity
- (2018) Qing Pan et al. PLoS One
- Association of HER2 gene amplification and tumor progression in early gastric cancer
- (2018) Kazuki Kanayama et al. VIRCHOWS ARCHIV
- Diagnostic role of carbohydrate antigen 72‐4 for gastrointestinal malignancy screening in Chinese patients: A prospective study
- (2018) Shu Ling Wang et al. Journal of Digestive Diseases
- The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma
- (2018) Junhun Cho et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic Tools in Patients With Advanced Cancer: A Systematic Review
- (2017) Claribel P.L. Simmons et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
- (2017) Yvette N. Lamb et al. Molecular Diagnosis & Therapy
- Population screening and treatment of Helicobacter pylori infection
- (2017) Anthony O'Connor et al. Nature Reviews Gastroenterology & Hepatology
- SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients
- (2017) Lu Bai et al. ONCOLOGY REPORTS
- A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
- (2017) Jing Guo et al. Oncotarget
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer
- (2016) Ying-qiu Pan et al. HUMAN IMMUNOLOGY
- Nationwide Multicenter Reference Interval Study for 28 Common Biochemical Analytes in China
- (2016) Liangyu Xia et al. MEDICINE
- CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4
- (2016) Xinyu Yan et al. Nanoscale Research Letters
- Associations between serum CA724 and HER2 overexpression among stage II–III resectable gastric cancer patients: an observational study
- (2016) Xin-Zu Chen et al. Oncotarget
- CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4
- (2016) Xinyu Yan et al. Nanoscale Research Letters
- Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer
- (2015) Li-Kui Yin et al. Asian Pacific Journal of Cancer Prevention
- Ultrasensitive electrochemical immunosensor for carbohydrate antigen 72-4 based on dual signal amplification strategy of nanoporous gold and polyaniline–Au asymmetric multicomponent nanoparticles
- (2015) Haixia Fan et al. BIOSENSORS & BIOELECTRONICS
- Advances in Molecular Biomarkers for Gastric Cancer
- (2015) Tang-Hui Zheng et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Sandwich-type electrochemical immunosensor using dumbbell-like nanoparticles for the determination of gastric cancer biomarker CA72-4
- (2015) Dan Wu et al. TALANTA
- Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
- (2015) Zhipeng Sun et al. World Journal of Surgical Oncology
- CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer
- (2014) Ai-Ping Yang et al. CLINICA CHIMICA ACTA
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer
- (2014) Qing Wang et al. MEDICAL ONCOLOGY
- Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents
- (2014) Hark Kyun Kim et al. PHARMACOGENOMICS
- Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids
- (2014) Masahiro Tsujiura WORLD JOURNAL OF GASTROENTEROLOGY
- The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment
- (2013) Fangxuan Li et al. BIOMARKERS
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
- (2013) Hideaki Shimada et al. Gastric Cancer
- Prognostic significance of tumour markers in Chinese patients with gastric cancer
- (2012) Xiaowen Liu et al. ANZ JOURNAL OF SURGERY
- Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population
- (2012) Xin-Zu Chen et al. MOLECULAR BIOLOGY REPORTS
- Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
- (2012) J. R. Prensner et al. Science Translational Medicine
- Reference values of thirty-one frequently used laboratory markers for 75-year-old males and females
- (2012) Ingvar Ryden et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
- (2011) Shigenobu Emoto et al. Gastric Cancer
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy
- (2011) Dae Hoon Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Improved efficacy of α-particle-targeted radiation therapy
- (2010) Diane E. Milenic et al. CANCER
- Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays
- (2009) Fabio Gasparri et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer
- (2008) Edip Ucar et al. ADVANCES IN THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started